Mohammad Noshi
Principal investigator, leads Akanocure Pharmaceuticals, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.2MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 30, 2024 | NSF | SBIR Phase II SBIR Phase II: A Novel Host-Directed Broad-Spectrum Antiviral and Efficient Immunomodulatory Agent Against Coronaviruses: Lead Optimization Studies | $1.0M | Akanocure Pharmaceuticals, Inc. |
| Mar 18, 2020 | NSF | SBIR Phase II SBIR Phase II: Multiplex Expansion of the Chiral Carbon Catalog Platform towards Stereo-enriched Non-propionate Chemical Classes and Industrial Applications | $950K | Akanocure Pharmaceuticals, Inc. |
| Dec 20, 2017 | NSF | SBIR Phase I SBIR Phase I: Novel Stereo-enriched Libraries as Commercial Complex Building Blocks for Facile Development of Biologically Active Compounds on Large Scale | $225K | Akanocure Pharmaceuticals, Inc. |
Peer ranks
Federal funding#913
Awards as PI#822
Patents#273
Companies
- Akanocure Pharmaceuticals, Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.